Published in EMBO J on June 02, 2003
Drosophila RNAi screen identifies host genes important for influenza virus replication. Nature (2008) 4.18
Influenza virus PB1-F2 protein induces cell death through mitochondrial ANT3 and VDAC1. PLoS Pathog (2005) 3.44
Lethal influenza virus infection in macaques is associated with early dysregulation of inflammatory related genes. PLoS Pathog (2009) 2.44
Influenza A virus NS1 protein activates the PI3K/Akt pathway to mediate antiapoptotic signaling responses. J Virol (2007) 2.44
Influenza A virus inhibits type I IFN signaling via NF-kappaB-dependent induction of SOCS-3 expression. PLoS Pathog (2008) 1.94
Caspase 3-dependent cell death of neurons contributes to the pathogenesis of West Nile virus encephalitis. J Virol (2006) 1.86
Influenza virus infection increases p53 activity: role of p53 in cell death and viral replication. J Virol (2005) 1.47
Human cytomegalovirus protein pUL38 induces ATF4 expression, inhibits persistent JNK phosphorylation, and suppresses endoplasmic reticulum stress-induced cell death. J Virol (2009) 1.38
NF-kappaB signaling differentially regulates influenza virus RNA synthesis. J Virol (2008) 1.38
H5N1 avian influenza virus induces apoptotic cell death in mammalian airway epithelial cells. J Virol (2008) 1.32
Sialidase activity of influenza A virus in an endocytic pathway enhances viral replication. J Virol (2005) 1.31
Avian influenza virus A/HK/483/97(H5N1) NS1 protein induces apoptosis in human airway epithelial cells. J Virol (2008) 1.27
Cell death in health and disease. J Cell Mol Med (2007) 1.27
Emerging roles for the influenza A virus nuclear export protein (NEP). PLoS Pathog (2012) 1.23
Caspases mediate processing of the capsid precursor and cell release of human astroviruses. J Virol (2004) 1.21
Lack of Bax prevents influenza A virus-induced apoptosis and causes diminished viral replication. J Virol (2009) 1.17
Bcl-2 expression and p38MAPK activity in cells infected with influenza A virus: impact on virally induced apoptosis and viral replication. J Biol Chem (2009) 1.07
Cellular microRNA let-7c inhibits M1 protein expression of the H1N1 influenza A virus in infected human lung epithelial cells. J Cell Mol Med (2012) 1.06
Glycyrrhizin exerts antioxidative effects in H5N1 influenza A virus-infected cells and inhibits virus replication and pro-inflammatory gene expression. PLoS One (2011) 1.06
Influenza virus induces apoptosis via BAD-mediated mitochondrial dysregulation. J Virol (2012) 1.01
Efficient influenza A virus replication in the respiratory tract requires signals from TLR7 and RIG-I. Proc Natl Acad Sci U S A (2013) 1.00
Innate immunity to influenza virus: implications for future therapy. Expert Rev Clin Immunol (2008) 0.99
Reverse-phase phosphoproteome analysis of signaling pathways induced by Rift valley fever virus in human small airway epithelial cells. PLoS One (2010) 0.98
Microarray analysis of microRNA expression in peripheral blood mononuclear cells of critically ill patients with influenza A (H1N1). BMC Infect Dis (2013) 0.98
Influenza virus A infection of human monocyte and macrophage subpopulations reveals increased susceptibility associated with cell differentiation. PLoS One (2012) 0.97
Rapid death of duck cells infected with influenza: a potential mechanism for host resistance to H5N1. Immunol Cell Biol (2011) 0.95
Highly pathogenic avian influenza A virus H5N1 NS1 protein induces caspase-dependent apoptosis in human alveolar basal epithelial cells. Virol J (2010) 0.95
Selenium deficiency alters epithelial cell morphology and responses to influenza. Free Radic Biol Med (2007) 0.93
Host gene targets for novel influenza therapies elucidated by high-throughput RNA interference screens. FASEB J (2012) 0.93
Sulfatide is required for efficient replication of influenza A virus. J Virol (2008) 0.93
Sphingosine 1-phosphate-metabolizing enzymes control influenza virus propagation and viral cytopathogenicity. J Virol (2010) 0.93
Influenza A virus nucleoprotein induces apoptosis in human airway epithelial cells: implications of a novel interaction between nucleoprotein and host protein Clusterin. Cell Death Dis (2013) 0.93
Transport of the influenza virus genome from nucleus to nucleus. Viruses (2013) 0.91
The influenza A virus protein PB1-F2: killing two birds with one stone? Virulence (2011) 0.90
Role of hypercytokinemia in NF-kappaB p50-deficient mice after H5N1 influenza A virus infection. J Virol (2008) 0.90
The ATF6 branch of unfolded protein response and apoptosis are activated to promote African swine fever virus infection. Cell Death Dis (2012) 0.89
Prostate tumor cells infected with a recombinant influenza virus expressing a truncated NS1 protein activate cytolytic CD8+ cells to recognize noninfected tumor cells. J Virol (2006) 0.88
Mechanisms of pathogenesis induced by bovine leukemia virus as a model for human T-cell leukemia virus. Front Microbiol (2013) 0.88
Contribution of caspase(s) to the cell cycle regulation at mitotic phase. PLoS One (2011) 0.88
Bacterial secreted effectors and caspase-3 interactions. Cell Microbiol (2014) 0.88
Oncolytic effects of a novel influenza A virus expressing interleukin-15 from the NS reading frame. PLoS One (2012) 0.87
mTOR/p70S6K signaling distinguishes routine, maintenance-level autophagy from autophagic cell death during influenza A infection. Virology (2014) 0.87
Influenza virus-induced caspase-dependent enlargement of nuclear pores promotes nuclear export of viral ribonucleoprotein complexes. J Virol (2015) 0.86
Compounds with anti-influenza activity: present and future of strategies for the optimal treatment and management of influenza. Part I: Influenza life-cycle and currently available drugs. J Prev Med Hyg (2014) 0.86
The clinically approved proteasome inhibitor PS-341 efficiently blocks influenza A virus and vesicular stomatitis virus propagation by establishing an antiviral state. J Virol (2010) 0.86
Cell death regulation during influenza A virus infection by matrix (M1) protein: a model of viral control over the cellular survival pathway. Cell Death Dis (2011) 0.86
A viral caspase contributes to modified apoptosis for virus transmission. Genes Dev (2005) 0.86
Cleavage of the Junin virus nucleoprotein serves a decoy function to inhibit the induction of apoptosis during infection. J Virol (2012) 0.85
β-catenin promotes the type I IFN synthesis and the IFN-dependent signaling response but is suppressed by influenza A virus-induced RIG-I/NF-κB signaling. Cell Commun Signal (2014) 0.85
Early responses of natural killer cells in pigs experimentally infected with 2009 pandemic H1N1 influenza A virus. PLoS One (2014) 0.84
Knockdown of specific host factors protects against influenza virus-induced cell death. Cell Death Dis (2013) 0.83
Chandipura virus induces neuronal death through Fas-mediated extrinsic apoptotic pathway. J Virol (2013) 0.83
Interaction of Hsp40 with influenza virus M2 protein: implications for PKR signaling pathway. Protein Cell (2010) 0.82
Lung epithelial cells resist influenza A infection by inducing the expression of cytochrome c oxidase VIc which is modulated by miRNA 4276. Virology (2014) 0.82
Mutations in the M-gene segment can substantially increase replication efficiency of NS1 deletion influenza A virus in MDCK cells. J Virol (2012) 0.82
Caspases activation in hyperthermia-induced stimulation of TRAIL apoptosis. Cell Stress Chaperones (2008) 0.82
Compounds with anti-influenza activity: present and future of strategies for the optimal treatment and management of influenza. Part II: Future compounds against influenza virus. J Prev Med Hyg (2014) 0.81
Stabilization of p53 in influenza A virus-infected cells is associated with compromised MDM2-mediated ubiquitination of p53. J Biol Chem (2012) 0.80
Cellular protein HAX1 interacts with the influenza A virus PA polymerase subunit and impedes its nuclear translocation. J Virol (2012) 0.80
Apoptosis and pro-inflammatory cytokine response of mast cells induced by influenza A viruses. PLoS One (2014) 0.80
The NS1 protein of influenza A virus blocks RIG-I-mediated activation of the noncanonical NF-κB pathway and p52/RelB-dependent gene expression in lung epithelial cells. J Virol (2012) 0.80
Syndecan-1 Attenuates Lung Injury during Influenza Infection by Potentiating c-Met Signaling to Suppress Epithelial Apoptosis. Am J Respir Crit Care Med (2016) 0.80
Analysis of host- and strain-dependent cell death responses during infectious salmon anemia virus infection in vitro. Virol J (2009) 0.79
Cellular players in the herpes simplex virus dependent apoptosis balancing act. Viruses (2009) 0.79
Effects of Zhichan powder on signal transduction and apoptosis-associated gene expression in the substantia nigra of Parkinson's disease rats. Neural Regen Res (2012) 0.78
N-glycolylneuraminic acid on human epithelial cells prevents entry of influenza A viruses that possess N-glycolylneuraminic acid binding ability. J Virol (2014) 0.78
CK2beta gene silencing increases cell susceptibility to influenza A virus infection resulting in accelerated virus entry and higher viral protein content. J Mol Signal (2008) 0.78
In vitro anti-influenza virus activities of a new lignan glycoside from the latex of Calotropis gigantea. PLoS One (2014) 0.78
Sulfatide regulates caspase-3-independent apoptosis of influenza A virus through viral PB1-F2 protein. PLoS One (2013) 0.78
Host defense mechanism-based rational design of live vaccine. PLoS One (2013) 0.77
The Feat of Packaging Eight Unique Genome Segments. Viruses (2016) 0.77
Therapy of experimental influenza virus infection with pyrrolidine dithiocarbamate. Med Microbiol Immunol (2010) 0.77
Nucleoprotein of influenza A virus negatively impacts antiapoptotic protein API5 to enhance E2F1-dependent apoptosis and virus replication. Cell Death Dis (2015) 0.77
Characterization of four novel caspases from Litopenaeus vannamei (Lvcaspase2-5) and their role in WSSV infection through dsRNA-mediated gene silencing. PLoS One (2013) 0.77
The Influenza A Virus Genotype Determines the Antiviral Function of NF-κB. J Virol (2016) 0.75
Bithionol blocks pathogenicity of bacterial toxins, ricin, and Zika virus. Sci Rep (2016) 0.75
Bik Mediates Caspase-Dependent Cleavage of Viral Proteins to Promote Influenza A Virus Infection. Am J Respir Cell Mol Biol (2016) 0.75
The Chinese prescription lianhuaqingwen capsule exerts anti-influenza activity through the inhibition of viral propagation and impacts immune function. BMC Complement Altern Med (2017) 0.75
Increased Survivorship and Altered Cytokine Profile from Treatment of Influenza A H1N1-Infected Mice with Ekybion: A Drug Complex of Natural Extracts and Inorganic Compounds. Evid Based Complement Alternat Med (2010) 0.75
Selective incorporation of vRNP into influenza A virions determined by its specific interaction with M1 protein. Virology (2017) 0.75
Nuclear Translocation of Crk Adaptor Proteins by the Influenza A Virus NS1 Protein. Viruses (2016) 0.75
Characterization of a novel mutation in NS1 protein of influenza A virus induced by a chemical substance for the attenuation of pathogenicity. PLoS One (2015) 0.75
Pretreatment of mice with oligonucleotide prop5 protects them from influenza virus infections. Viruses (2014) 0.75
Highly pathogenic avian influenza H5N1 virus delays apoptotic responses via activation of STAT3. Sci Rep (2016) 0.75
Saikosaponin A inhibits influenza A virus replication and lung immunopathology. Oncotarget (2015) 0.75
Efficient suilysin-mediated invasion and apoptosis in porcine respiratory epithelial cells after streptococcal infection under air-liquid interface conditions. Sci Rep (2016) 0.75
Proteomic analysis reveals down-regulation of surfactant protein B in murine type II pneumocytes infected with influenza A virus. Virology (2015) 0.75
Host Genetic Background Strongly Affects Pulmonary microRNA Expression before and during Influenza A Virus Infection. Front Immunol (2017) 0.75
Viral hijacking of host caspases: an emerging category of pathogen-host interactions. Cell Death Differ (2017) 0.75
Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer (1972) 35.74
A system for stable expression of short interfering RNAs in mammalian cells. Science (2002) 35.21
Caspases: enemies within. Science (1998) 19.45
Caspases: the executioners of apoptosis. Biochem J (1997) 11.99
A novel influenza A virus mitochondrial protein that induces cell death. Nat Med (2001) 9.90
Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature (1998) 9.77
Yama/CPP32 beta, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell (1995) 9.22
X-linked IAP is a direct inhibitor of cell-death proteases. Nature (1997) 8.26
Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis. J Biol Chem (1998) 6.84
A plasmid-based reverse genetics system for influenza A virus. J Virol (1996) 4.33
Apoptosis: a mechanism of cell killing by influenza A and B viruses. J Virol (1994) 4.20
The influenza virus NEP (NS2 protein) mediates the nuclear export of viral ribonucleoproteins. EMBO J (1998) 3.98
Depletion of lymphocytes and diminished cytokine production in mice infected with a highly virulent influenza A (H5N1) virus isolated from humans. J Virol (2000) 3.88
Inhibition of interferon-mediated antiviral responses by influenza A viruses and other negative-strand RNA viruses. Virology (2001) 3.76
Homozygous deletion of the alpha- and beta 1-interferon genes in human leukemia and derived cell lines. Proc Natl Acad Sci U S A (1988) 3.67
Induction of programmed cell death (apoptosis) by influenza virus infection in tissue culture cells. J Gen Virol (1993) 3.08
Influenza virus propagation is impaired by inhibition of the Raf/MEK/ERK signalling cascade. Nat Cell Biol (2001) 2.93
Caspase 3 activity is required for skeletal muscle differentiation. Proc Natl Acad Sci U S A (2002) 2.88
Nuclear import and export of influenza virus nucleoprotein. J Virol (1997) 2.69
NS1 protein of influenza A virus down-regulates apoptosis. J Virol (2002) 2.12
Alpha/beta interferons potentiate virus-induced apoptosis through activation of the FADD/Caspase-8 death signaling pathway. J Virol (2000) 2.11
Programmed cell death (apoptosis) in human monocytes infected by influenza A virus. Immunobiology (1994) 1.98
Serial killers: ordering caspase activation events in apoptosis. Cell Death Differ (1999) 1.97
Apoptosis in viral infections. Adv Virus Res (1995) 1.97
Caspases disrupt the nuclear-cytoplasmic barrier. J Cell Biol (2000) 1.84
Phosphatidylserine, a death knell. Cell Death Differ (2001) 1.74
bcl-2 alters influenza virus yield, spread, and hemagglutinin glycosylation. J Virol (1996) 1.69
Influenza virus ns1 protein induces apoptosis in cultured cells. J Virol (2001) 1.67
In vivo induction of apoptosis by influenza virus. J Gen Virol (1995) 1.65
Caspase-dependent N-terminal cleavage of influenza virus nucleocapsid protein in infected cells. J Virol (1999) 1.61
A fatal relationship--influenza virus interactions with the host cell. Viral Immunol (1999) 1.54
Destruction of lymphocytes by a virulent avian influenza A virus. J Gen Virol (1989) 1.52
Virulent avian influenza A viruses: their effect on avian lymphocytes and macrophages in vivo and in vitro. J Gen Virol (1989) 1.49
Human lymphocyte apoptosis after exposure to influenza A virus. J Virol (2001) 1.31
Influenza virus-induced AP-1-dependent gene expression requires activation of the JNK signaling pathway. J Biol Chem (2001) 1.30
Recruitment of apoptotic cysteine proteases (caspases) in influenza virus-induced cell death. Microbiol Immunol (1999) 1.15
Neurotrophin receptor-interacting mage homologue is an inducible inhibitor of apoptosis protein-interacting protein that augments cell death. J Biol Chem (2001) 1.00
Caspase activation in equine influenza virus induced apoptotic cell death. Vet Microbiol (2002) 0.88
Role of phosphatidylserine exposure and sugar chain desialylation at the surface of influenza virus-infected cells in efficient phagocytosis by macrophages. J Biol Chem (2002) 0.83
Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock. Nat Med (2007) 5.47
Influenza A virus NS1 protein activates the PI3K/Akt pathway to mediate antiapoptotic signaling responses. J Virol (2007) 2.44
Lung epithelial apoptosis in influenza virus pneumonia: the role of macrophage-expressed TNF-related apoptosis-inducing ligand. J Exp Med (2008) 2.30
The influenza A virus NS1 protein inhibits activation of Jun N-terminal kinase and AP-1 transcription factors. J Virol (2002) 2.14
Influenza virus infection aggravates stroke outcome. Stroke (2011) 2.13
IFN-alpha antagonistic activity of HCV core protein involves induction of suppressor of cytokine signaling-3. FASEB J (2003) 2.00
Influenza A virus inhibits type I IFN signaling via NF-kappaB-dependent induction of SOCS-3 expression. PLoS Pathog (2008) 1.94
Bivalent role of the phosphatidylinositol-3-kinase (PI3K) during influenza virus infection and host cell defence. Cell Microbiol (2006) 1.94
The proapoptotic influenza A virus protein PB1-F2 regulates viral polymerase activity by interaction with the PB1 protein. Cell Microbiol (2008) 1.90
Alveolar epithelial cells direct monocyte transepithelial migration upon influenza virus infection: impact of chemokines and adhesion molecules. J Immunol (2006) 1.89
Early events in the thymus affect the balance of effector and regulatory T cells. Nature (2006) 1.78
Ringing the alarm bells: signalling and apoptosis in influenza virus infected cells. Cell Microbiol (2006) 1.77
Macrophage-expressed IFN-β contributes to apoptotic alveolar epithelial cell injury in severe influenza virus pneumonia. PLoS Pathog (2013) 1.74
The epidermal growth factor receptor (EGFR) promotes uptake of influenza A viruses (IAV) into host cells. PLoS Pathog (2010) 1.73
MRP8 and MRP14 control microtubule reorganization during transendothelial migration of phagocytes. Blood (2004) 1.71
Influenza-virus-induced signaling cascades: targets for antiviral therapy? Trends Mol Med (2003) 1.64
Cytomegalovirus and tumor stress surveillance by binding of a human γδ T cell antigen receptor to endothelial protein C receptor. Nat Immunol (2012) 1.61
NF-kappaB-dependent induction of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and Fas/FasL is crucial for efficient influenza virus propagation. J Biol Chem (2004) 1.59
Transcriptional profiling of IKK2/NF-kappa B- and p38 MAP kinase-dependent gene expression in TNF-alpha-stimulated primary human endothelial cells. Blood (2004) 1.56
Highly pathogenic influenza virus infection of the thymus interferes with T lymphocyte development. J Immunol (2010) 1.51
A new player in a deadly game: influenza viruses and the PI3K/Akt signalling pathway. Cell Microbiol (2009) 1.50
Viral targeting of the interferon-{beta}-inducing Traf family member-associated NF-{kappa}B activator (TANK)-binding kinase-1. Proc Natl Acad Sci U S A (2005) 1.49
MAPKAP kinase 3pK phosphorylates and regulates chromatin association of the polycomb group protein Bmi1. J Biol Chem (2004) 1.48
Rac1 and PAK1 are upstream of IKK-epsilon and TBK-1 in the viral activation of interferon regulatory factor-3. FEBS Lett (2004) 1.47
Interplay between influenza A virus and the innate immune signaling. Microbes Infect (2009) 1.43
Pathogenicity of different PR8 influenza A virus variants in mice is determined by both viral and host factors. Virology (2011) 1.28
Regulation of suppressor of cytokine signaling 3 (SOCS3) mRNA stability by TNF-alpha involves activation of the MKK6/p38MAPK/MK2 cascade. J Immunol (2007) 1.27
Erk5 activation elicits a vasoprotective endothelial phenotype via induction of Kruppel-like factor 4 (KLF4). J Biol Chem (2010) 1.25
A polyphenol rich plant extract, CYSTUS052, exerts anti influenza virus activity in cell culture without toxic side effects or the tendency to induce viral resistance. Antiviral Res (2007) 1.24
Neonates harbour highly active gammadelta T cells with selective impairments in preterm infants. Eur J Immunol (2009) 1.23
The NS segment of an H5N1 highly pathogenic avian influenza virus (HPAIV) is sufficient to alter replication efficiency, cell tropism, and host range of an H7N1 HPAIV. J Virol (2009) 1.20
Apoptosis signaling in influenza virus propagation, innate host defense, and lung injury. J Leukoc Biol (2012) 1.19
The immunopathogenesis of Borna disease virus infection. Front Biosci (2002) 1.17
Acetylsalicylic acid (ASA) blocks influenza virus propagation via its NF-kappaB-inhibiting activity. Cell Microbiol (2007) 1.17
Influenza viruses control the vertebrate type I interferon system: factors, mechanisms, and consequences. J Interferon Cytokine Res (2009) 1.17
The contact allergen nickel triggers a unique inflammatory and proangiogenic gene expression pattern via activation of NF-kappaB and hypoxia-inducible factor-1alpha. J Immunol (2007) 1.14
Membrane accumulation of influenza A virus hemagglutinin triggers nuclear export of the viral genome via protein kinase Calpha-mediated activation of ERK signaling. J Biol Chem (2006) 1.14
Phosphatidylinositol-3-kinase (PI3K) is activated by influenza virus vRNA via the pathogen pattern receptor Rig-I to promote efficient type I interferon production. Cell Microbiol (2011) 1.14
Essential impact of NF-kappaB signaling on the H5N1 influenza A virus-induced transcriptome. J Immunol (2009) 1.13
Synergistic adaptive mutations in the hemagglutinin and polymerase acidic protein lead to increased virulence of pandemic 2009 H1N1 influenza A virus in mice. J Infect Dis (2011) 1.12
Activation of MAP kinase p38 is critical for the cell-cycle-controlled suppressor function of regulatory T cells. Blood (2007) 1.10
The influenza virus PB1-F2 protein has interferon antagonistic activity. Biol Chem (2011) 1.08
Phosphorylation of the influenza A virus protein PB1-F2 by PKC is crucial for apoptosis promoting functions in monocytes. Cell Microbiol (2009) 1.08
H5N1 virus activates signaling pathways in human endothelial cells resulting in a specific imbalanced inflammatory response. J Immunol (2010) 1.07
Interleukin-27 displays interferon-gamma-like functions in human hepatoma cells and hepatocytes. Hepatology (2009) 1.07
Higher polymerase activity of a human influenza virus enhances activation of the hemagglutinin-induced Raf/MEK/ERK signal cascade. Virol J (2007) 1.05
Combined action of influenza virus and Staphylococcus aureus panton-valentine leukocidin provokes severe lung epithelium damage. J Infect Dis (2012) 1.03
The mRNA transcription/processing factor Ssu72 is a potential tyrosine phosphatase. J Biol Chem (2003) 1.03
Candida albicans triggers activation of distinct signaling pathways to establish a proinflammatory gene expression program in primary human endothelial cells. J Immunol (2007) 1.00
PAR1 contributes to influenza A virus pathogenicity in mice. J Clin Invest (2012) 1.00
A new splice variant of the human guanylate-binding protein 3 mediates anti-influenza activity through inhibition of viral transcription and replication. FASEB J (2011) 1.00
Spread of infection and lymphocyte depletion in mice depends on polymerase of influenza virus. Am J Pathol (2009) 0.99
MEK inhibition impairs influenza B virus propagation without emergence of resistant variants. FEBS Lett (2004) 0.99
Influenza viruses and the NF-kappaB signaling pathway - towards a novel concept of antiviral therapy. Biol Chem (2008) 0.98
Antiviral activity of the MEK-inhibitor U0126 against pandemic H1N1v and highly pathogenic avian influenza virus in vitro and in vivo. Antiviral Res (2011) 0.97
Low-dose interferon Type I treatment is effective against H5N1 and swine-origin H1N1 influenza A viruses in vitro and in vivo. J Interferon Cytokine Res (2011) 0.96
Molecular analysis of tumor-promoting CD8+ T cells in two-stage cutaneous chemical carcinogenesis. J Invest Dermatol (2009) 0.95
CYSTUS052, a polyphenol-rich plant extract, exerts anti-influenza virus activity in mice. Antiviral Res (2007) 0.95
NS reassortment of an H7-type highly pathogenic avian influenza virus affects its propagation by altering the regulation of viral RNA production and antiviral host response. J Virol (2010) 0.95
CL-385319 inhibits H5N1 avian influenza A virus infection by blocking viral entry. Eur J Pharmacol (2011) 0.95